TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33316455

Group type: EXPERIMENTAL
Intervention: PAP therapy with lifestyle counseling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lifestyle counseling alone
Number of subjects: 0
Study: 36480147

Group type: EXPERIMENTAL
Intervention: Intravenous lysine acetylsalicylate (LA) 450 mg plus oral ticagrelor 180 mg
Number of subjects: 32

Group type: COMPARATOR
Intervention: Oral aspirin 300 mg plus ticagrelor 180 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Intravenous lysine acetylsalicylate (LA)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Oral aspirin
Number of subjects: 32
Study: 34453015

Group type: EXPERIMENTAL
Intervention: Hybrid program based on virtual and real games
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional program based on adapted sports
Number of subjects: 24
Study: 32571870

Group type: EXPERIMENTAL
Intervention: Canakinumab 150 or 300 mg, every 4 or 8 weeks during a 72-week period
Number of subjects: 61
Study: 34508154

Group type: EXPERIMENTAL
Intervention: Prescribed pace
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treadmill
Number of subjects: 0

Group type: COMPARATOR
Intervention: Overweight individuals
Number of subjects: 0
Study: 34535961

Group type: EXPERIMENTAL
Intervention: Dietary intervention
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Increased physical activity
Number of subjects: 219
Study: 36382458

Group type: EXPERIMENTAL
Intervention: Automatic identification model based on knee MRI radiomics
Number of subjects: 228
Study: 32961834

Group type: EXPERIMENTAL
Intervention: Electronic activity monitor
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pedometer
Number of subjects: 40
Study: 35658959

Group type: EXPERIMENTAL
Intervention: IF2-P
Number of subjects: 20

Group type: COMPARATOR
Intervention: IF1-P
Number of subjects: 20
Study: 32238534

Group type: EXPERIMENTAL
Intervention: P‐ESDM plus MBSR
Number of subjects: 61

Group type: COMPARATOR
Intervention: P‐ESDM only
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 61
Study: 34000940

Group type: EXPERIMENTAL
Intervention: Individualized-Targeted Cognitive Training
Number of subjects: 109

Group type: COMPARATOR
Intervention: No-contact control group (no training)
Number of subjects: 109
Study: 34406839

Group type: EXPERIMENTAL
Intervention: Mindful awareness practices (MAPs)
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Survivorship education (SE)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Wait-list control (WLC)
Number of subjects: 247
Study: 32492682

Group type: EXPERIMENTAL
Intervention: EBUS-Strain Elastography (SE) with mean strain <115
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: Combination of EBUS-SE (<115) with size (<8 mm) and FDG-PET information
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: Combination of size and SE
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: FDG-PET available subset analysis
Number of subjects: 327
Study: 32245307

Group type: EXPERIMENTAL
Intervention: Guluronic acid (G2013) administered orally at a dose of 500 mg twice daily for 12 weeks
Number of subjects: 12
Study: 35027330

Group type: EXPERIMENTAL
Intervention: Suburethral adjustment-controlled tape (SACT)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Transobturator tape (TOT) midurethral sling (MUS)
Number of subjects: 125
Study: 34101934

Group type: EXPERIMENTAL
Intervention: NEPA plus single-dose DEX (12 mg on day 1) with no further DEX (DEX1)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: NEPA plus single-dose DEX (12 mg on day 1) with oral DEX (4 mg daily) on days 2-3 (DEX3)
Number of subjects: 228

Group type: COMPARATOR
Intervention: DEX (4 mg twice daily) on days 2-4 (DEX4)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: All groups (DEX1, DEX3, DEX4)
Number of subjects: 228
Study: 33048789

Group type: EXPERIMENTAL
Intervention: HAART
Number of subjects: 65
Study: 34990999

Group type: EXPERIMENTAL
Intervention: rTMS intervention (20 daily sessions, 900 pulses per day for 4 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 40
Study: 34091568

Group type: EXPERIMENTAL
Intervention: Nurse-led cognitive behavioral therapy intervention
Number of subjects: 94
Study: 32429867

Group type: EXPERIMENTAL
Intervention: The Guide Cymru (mental health literacy programme)
Number of subjects: 30000

Group type: COMPARATOR
Intervention: Wait-list control (no intervention initially)
Number of subjects: 30000

Group type: EXPERIMENTAL
Intervention: The Guide Cymru (after 12 weeks for control group)
Number of subjects: 30000

Group type: EXPERIMENTAL
Intervention: The Guide Cymru
Number of subjects: 30000
Study: 33605168

Group type: EXPERIMENTAL
Intervention: Play it Safe! program (intervention group)
Number of subjects: 539

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 539
Study: 33287581

Group type: EXPERIMENTAL
Intervention: Early pulmonary rehabilitation (DHPR)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Delayed pulmonary rehabilitation (PHPR)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Adverse events in DHPR
Number of subjects: 53
Study: 35533665

Group type: EXPERIMENTAL
Intervention: Multidisciplinary educational program (9-week duration)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no educational program)
Number of subjects: 64
Study: 33982473

Group type: EXPERIMENTAL
Intervention: Certain herbal preparation for the treatment of non-severe influenza
Number of subjects: 0

Group type: COMPARATOR
Intervention: Internationally recognized positive drugs or guidelines
Number of subjects: 0
Study: 32667982

Group type: EXPERIMENTAL
Intervention: Daptomycin
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Daptomycin (modified intention-to-treat)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo (modified intention-to-treat)
Number of subjects: 104
Study: 35589362

Group type: EXPERIMENTAL
Intervention: Whitu app
Number of subjects: 90
Study: 32546012

Group type: EXPERIMENTAL
Intervention: Behaviour monitoring
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Habit monitoring
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Irrelevant behaviour monitoring
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Cued behaviour
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Not cued behaviour
Number of subjects: 186

Group type: COMPARATOR
Intervention: Post-intervention measures
Number of subjects: 186
Study: 32423408

Group type: EXPERIMENTAL
Intervention: RIPASA score
Number of subjects: 79

Group type: COMPARATOR
Intervention: Tzanakis score
Number of subjects: 79
Study: 36286314

Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 33420076

Group type: EXPERIMENTAL
Intervention: Biological network
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized counterpart of the E. coli transcription network
Number of subjects: 0
Study: 33935219

Group type: EXPERIMENTAL
Intervention: Four Square Step Test (FSST) performance
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cognitive tests (3MS, HVOT, TMT-B)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Fracture characteristics (fracture side and type)
Number of subjects: 40
Study: 35649597

Group type: EXPERIMENTAL
Intervention: Self-fatigue assessment group using the Borg Exercise Scale to assess fatigue, stopping activity at fatigue level 5-6.
Number of subjects: 552

Group type: COMPARATOR
Intervention: Fixed activity distance assessment group (control group).
Number of subjects: 552

Group type: EXPERIMENTAL
Intervention: Self-fatigue assessment group.
Number of subjects: 552
Study: 32946806

Group type: EXPERIMENTAL
Intervention: Anodal tDCS over the left PFC
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 48
Study: 36036185

Group type: EXPERIMENTAL
Intervention: Simulation Based Education (SBE)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional Education (CE)
Number of subjects: 24
Study: 32811575

Group type: EXPERIMENTAL
Intervention: Psilocybin therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psilocybin therapy with SSRIs
Number of subjects: 0
Study: 34755287

Group type: EXPERIMENTAL
Intervention: Quxie Capsule combined with conventional therapy (chemotherapy, radiotherapy, targeted therapy, supportive care)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo combined with conventional therapy (chemotherapy, radiotherapy, targeted therapy, supportive care)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Quxie Capsule in subgroup analysis (⩾second-line therapy, non-targeted therapy, RAS gene wild type, left-sided colon)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 33618683

Group type: EXPERIMENTAL
Intervention: Tamoxifen treatment for 2 years
Number of subjects: 560

Group type: COMPARATOR
Intervention: No adjuvant treatment
Number of subjects: 560
Study: 32129208

Group type: EXPERIMENTAL
Intervention: Training based on Lazarus and Folkman transactional model
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 116
Study: 35947039

Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 33367924

Group type: EXPERIMENTAL
Intervention: Radial extracorporeal shock wave therapy at 0.12 mJ/mm2, 2,000 impulses
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Radial extracorporeal shock wave therapy at 0.12 mJ/mm2, 4,000 impulses
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Radial extracorporeal shock wave therapy at 0.24 mJ/mm2, 2,000 impulses
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Radial extracorporeal shock wave therapy at 0.24 mJ/mm2, 4,000 impulses
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 89
Study: 32086006

Group type: EXPERIMENTAL
Intervention: Experimental training (four training sessions pushing away thin body pictures and pulling closer realistic pictures)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo training (same stimuli shown with 50/50 contingency)
Number of subjects: 104

Group type: COMPARATOR
Intervention: No training control condition
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Experimental training
Number of subjects: 104
Study: 35181928

Group type: EXPERIMENTAL
Intervention: Behavioral treatment for overactive bladder
Number of subjects: 26
Study: 34114250

Group type: EXPERIMENTAL
Intervention: Active MDMA (75-125 mg)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo/control MDMA (0-40 mg)
Number of subjects: 63
Study: 32195928

Group type: EXPERIMENTAL
Intervention: Acupuncture (various types including simple acupuncture, fire needle, warm acupuncture, auriculo-acupuncture, electroacupuncture)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pharmacological agents (not specified)
Number of subjects: 0
Study: 34380382

Group type: EXPERIMENTAL
Intervention: 1100 mg coffee berry extract
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 1100 mg coffee berry extract plus 275 mg apple extract
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 100 mg coffee berry extract plus 275 mg apple extract
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 33172509

Group type: EXPERIMENTAL
Intervention: EEM group (eating at 19.00‐19.30 hours)
Number of subjects: 82

Group type: COMPARATOR
Intervention: LEM group (eating at 22.30‐23.00 hours)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: EEM group
Number of subjects: 82

Group type: COMPARATOR
Intervention: LEM group
Number of subjects: 82
Study: 35649228

Group type: EXPERIMENTAL
Intervention: Hepatic arterial infusion pump (HAIP) chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drug‐eluting beads coated with irinotecan transarterial chemoembolization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transarterial radioembolization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HAIP, transarterial chemoembolization, and transarterial radioembolization
Number of subjects: 0
Study: 33035097

Group type: EXPERIMENTAL
Intervention: Sacral neuromodulation (SNM) therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Axonics SNM System®
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SNM therapy options
Number of subjects: 0
Study: 35781432

Group type: EXPERIMENTAL
Intervention: Biodentine (Septodont) with 2.5% sodium hypochlorite irrigation
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: PD-MTA White (Produits Dentaires) with 2.5% sodium hypochlorite irrigation
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: K-Biocer (REKITA) with 2.5% sodium hypochlorite irrigation
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (irrigation not specified)
Number of subjects: 90
Study: 34544939

Group type: EXPERIMENTAL
Intervention: Intravenous Itraconazole 200 mg
Number of subjects: 850

Group type: COMPARATOR
Intervention: Liposomal Amphotericin B 3.0 mg/kg once daily
Number of subjects: 850
Study: 35013898

Group type: EXPERIMENTAL
Intervention: Multifactorial intervention in addition to standard care
Number of subjects: 82

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 82
Study: 32053522

Group type: EXPERIMENTAL
Intervention: Postoperative intravenous tranexamic acid (TXA) - 3 doses of 1,000 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo - 3 doses of intravenous normal saline solution
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Postoperative intravenous tranexamic acid (TXA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo - intravenous normal saline solution
Number of subjects: 100
Study: 35945094

Group type: EXPERIMENTAL
Intervention: a‐tDCS 1‐s Group (one daily a‐tDCS session)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: a‐tDCS 2‐s Group (two daily a‐tDCS sessions)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Group SHAM (one daily session with simulated current)
Number of subjects: 30
Study: 33886519

Group type: EXPERIMENTAL
Intervention: Video curriculum
Number of subjects: 60

Group type: COMPARATOR
Intervention: Reading group
Number of subjects: 60
Study: 35485297

Group type: EXPERIMENTAL
Intervention: Isometric exercise at 50% maximal voluntary isometric contraction (MVIC)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Isometric exercise at 75% maximal voluntary isometric contraction (MVIC)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Isometric exercise at 25% maximal voluntary isometric contraction (MVIC)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Comparison of 50% and 75% MVIC
Number of subjects: 13

Group type: COMPARATOR
Intervention: Comparison of 25% and 50% MVIC
Number of subjects: 13
Study: 35867804

Group type: EXPERIMENTAL
Intervention: istaroxime 1.0–1.5 μg/kg/min
Number of subjects: 60

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 60
Study: 32827729

Group type: EXPERIMENTAL
Intervention: Canakinumab 150 mg subcutaneously once at baseline
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Canakinumab
Number of subjects: 20
Study: 35381034

Group type: EXPERIMENTAL
Intervention: Settlement Services Literacy (SSL) scale, validated through exploratory factor analysis (EFA) and confirmatory factor analysis (CFA).
Number of subjects: 653
Study: 33065667

Group type: EXPERIMENTAL
Intervention: Transmetatarsal base screw
Number of subjects: 16

Group type: COMPARATOR
Intervention: Lisfranc screw
Number of subjects: 16
Study: 35484991

Group type: EXPERIMENTAL
Intervention: Intermittent theta burst stimulation (iTBS) of the left dorsolateral prefrontal cortex (DLPFC) for 2 weeks.
Number of subjects: 58

Group type: COMPARATOR
Intervention: Sham stimulation of the left dorsolateral prefrontal cortex for 2 weeks.
Number of subjects: 58
Study: 32515840

Group type: EXPERIMENTAL
Intervention: Biological mesh
Number of subjects: 24

Group type: COMPARATOR
Intervention: Synthetic mesh
Number of subjects: 24
Study: 35999487

Group type: EXPERIMENTAL
Intervention: Catheter torque tool
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard ablation catheter without torque tool
Number of subjects: 0
Study: 33599135

Group type: EXPERIMENTAL
Intervention: Left ventricular unloading for at least 30 minutes prior to coronary reperfusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current standard of care
Number of subjects: 0
Study: 32276594

Group type: EXPERIMENTAL
Intervention: Baseline diet quality assessed using the Dietary Guideline Index (DGI-2013)
Number of subjects: 837

Group type: EXPERIMENTAL
Intervention: Increase in DGI score over 5 years follow-up
Number of subjects: 837
Study: 35762581

Group type: EXPERIMENTAL
Intervention: DAPT with cilostazol plus aspirin or clopidogrel
Number of subjects: 1197
Study: 34227951

Group type: EXPERIMENTAL
Intervention: Early Essential Newborn Care (EENC) implementation
Number of subjects: 259
Study: 32960673

Group type: EXPERIMENTAL
Intervention: Radiomics model incorporating handcrafted-signature, deep-signature, and SCC-Ag levels
Number of subjects: 190

Group type: COMPARATOR
Intervention: Radiomics signature alone
Number of subjects: 190

Group type: COMPARATOR
Intervention: SCC-Ag level alone
Number of subjects: 190
Study: 34587328

Group type: EXPERIMENTAL
Intervention: House screening (HS) with permanently fixed fiberglass on all windows and doors
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: House screening (HS)
Number of subjects: 1200
Study: 35413573

Group type: EXPERIMENTAL
Intervention: Synbiotics combined with enteral nutrition (EN)
Number of subjects: 81
Study: 33172953

Group type: EXPERIMENTAL
Intervention: Novel, targeted, youth‐focussed sleep intervention in addition to usual care
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 40
Study: 34165794

Group type: EXPERIMENTAL
Intervention: Radiomic nomogram based on multivariate logistic analysis
Number of subjects: 28150

Group type: COMPARATOR
Intervention: Training set (n=18,766)
Number of subjects: 28150

Group type: COMPARATOR
Intervention: Validation set (n=9,384)
Number of subjects: 28150
Study: 33573017

Group type: EXPERIMENTAL
Intervention: POIBA intervention group (IG)
Number of subjects: 3624

Group type: COMPARATOR
Intervention: Comparison group (CG)
Number of subjects: 3624
Study: 35438424

Group type: EXPERIMENTAL
Intervention: Maximal strength training (MST)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 23
Study: 33639478

Group type: EXPERIMENTAL
Intervention: 3 months DAPT
Number of subjects: 1496

Group type: COMPARATOR
Intervention: 12 months DAPT
Number of subjects: 1496
Study: 32481297

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment in addition to basic treatment for sepsis
Number of subjects: 98

Group type: COMPARATOR
Intervention: Basic treatment for sepsis (Control group)
Number of subjects: 98
Study: 36394533

Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan
Number of subjects: 0

Group type: COMPARATOR
Intervention: valsartan
Number of subjects: 0
Study: 34600542

Group type: EXPERIMENTAL
Intervention: Pharmacist Independent Prescriber (PIP) intervention
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 25
Study: 35985506

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 106

Group type: COMPARATOR
Intervention: Testosterone
Number of subjects: 106

Group type: COMPARATOR
Intervention: Combination of Metformin and Testosterone
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 106
Study: 34251939

Group type: EXPERIMENTAL
Intervention: Y-chromosome-bearing sperm
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: X-chromosome-bearing sperm
Number of subjects: 50
Study: 32654539

Group type: EXPERIMENTAL
Intervention: Factor V Leiden carriers (heterozygous or homozygous)
Number of subjects: 69681

Group type: COMPARATOR
Intervention: Non-carriers of factor V Leiden
Number of subjects: 69681
Study: 36128795

Group type: EXPERIMENTAL
Intervention: Investigational Wearable Infusor (IWI)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Crono S-PID-50 infusion pump (CP)
Number of subjects: 23
Study: 32973057

Group type: EXPERIMENTAL
Intervention: Left bundle branch area pacing (LBBaP)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Biventricular pacing (Bi-V)
Number of subjects: 180
Study: 35042375

Group type: EXPERIMENTAL
Intervention: Dislike condition
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Nonconsent condition
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Said nothing condition
Number of subjects: 276
Study: 33569807

Group type: EXPERIMENTAL
Intervention: GTR, BPBM, and PRF
Number of subjects: 14

Group type: COMPARATOR
Intervention: GTR and BPBM
Number of subjects: 14
Study: 33546534

Group type: EXPERIMENTAL
Intervention: Intra-dermal Platelet Rich Plasma (PRP) 1 ml monthly for 3 months
Number of subjects: 92

Group type: COMPARATOR
Intervention: 50% Trichloracetic Acid (TCA) applied by CROSS technique monthly for 3 months
Number of subjects: 92
Study: 35658059

Group type: EXPERIMENTAL
Intervention: Cingulate tDCS
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 11
Study: 34550034

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 mg orally once daily
Number of subjects: 228

Group type: COMPARATOR
Intervention: Enoxaparin 4000 AxaIU (0.4 mL) subcutaneously once daily
Number of subjects: 228
Study: 32102687

Group type: EXPERIMENTAL
Intervention: Self-cut titanium-coated polypropylene mesh
Number of subjects: 312

Group type: COMPARATOR
Intervention: Mesh kit
Number of subjects: 312
Study: 33038432

Group type: EXPERIMENTAL
Intervention: Emricasan 5 mg
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Emricasan 25 mg
Number of subjects: 217

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Emricasan (both doses)
Number of subjects: 217
Study: 33008301

Group type: COMPARATOR
Intervention: Kato-Katz (KK) method
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Real-time PCR
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Moxidectin
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Moxidectin + Tribendimidine
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Moxidectin + Albendazole
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Albendazole + Oxantel pamoate
Number of subjects: 320
Study: 35241779

Group type: EXPERIMENTAL
Intervention: Mirtazapine (7.5–45 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 30